Labiotech.eu

News and Trends 26 Nov 2015

The UK-Israeli €378M Small-Molecule Offensive Against Migraines

The Israeli TEVA and UK Heptares Therapeutics (now owned by Japanese Sosei) have partnered up on novel drug therapies targeting Migraines. The pain and disruption migraines can cause pain that lasts from 4 to 72 hours, and around 10 million worldwide suffer such episodes on a regular basis. Signs and symptoms of a migraine include photosensitivity […]

November 26, 2015 - 2 minutesmins - By Dani Bancroft

biosimilar war neulasta herceptin avastin rituxan1

News and Trends 25 Nov 2015

Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!

Novartis is hitting back in the Biosimilar battleground: now Neulasta, the white blood cell booster for Cancer, is the latest of Amgen’s victims… Neulasta (pegfilgrastim) has been submitted through Novartis’ subsidiary, Sandoz. As a recombinant human granulocyte colony-stimulating factor (G-CSF), pegfilgrastim looks to stimulate the immune system and boost the white cell count. Neulasta is […]

November 25, 2015 - 4 minutesmins - By Dani Bancroft

News and Trends 25 Nov 2015

Why Biotech Companies Should Care About Native Advertising?

Biotech companies are constantly trying to reach consumers online, competing to grab a few minutes of their attention. Native Advertising is opening new opportunities for biotech companies to advertise online. Most of the marketing budgets are moving online. While display ads (banners) were the golden standard for a long time, this practice is rapidly changing. […]

November 25, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 24 Nov 2015

Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC

The World Leader in the Immuno-Oncology field has teamed up with a major German Investor to better identify breakthrough investment opportunities across the EU. Bristol-Myers Squibb (BMS) has partnered with Life Sciences Partners in Munich to highlight novel immuno-oncology technologies which could be the next blockbusters in the field. Together the two have conspired a […]

November 24, 2015 - 2 minutesmins - By Dani Bancroft

News and Trends 24 Nov 2015

2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?

Since both Alzheimer’s Disease and Parkinson’s combined affect up to 50 million people worldwide, it is no wonder this new wave of break-through milestones is getting the industry excited… The Central Nervous System (CNS) comprises many complex tissues and highly specialized cell types, mutation in which can cause an array of deadly and chronic diseases. […]

November 24, 2015 - 9 minutesmins - By Dani Bancroft

News and Trends 24 Nov 2015

Next Generation Sequencing: the final step to massively adopt Personalized Medicine

For several decades, physicians have been dreaming of a Personalized Medicine, able to treat patients according to their genetic profile. The development of Next Generation Sequencing techniques can be the ultimate step before a massive adoption of personalized medicine. The world of medicine is shifting from the traditional “one size fits all” approach to one […]

November 24, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 23 Nov 2015

Finally, Pfizer acquires Botox-maker Allergan for €150Bn to move to tax-friendly Ireland!

The Rumor became more and more tangleon what is now the biggest Pharma deal ever. The Rumor was pumped up by reports from Bloomberg and CNBC, saying the deal could be closed on Monday, as we reported here. And now it’s official. Just a few hours ago, Pfizer announced it agrees on buying Allergan for €150Bn […]

November 23, 2015 - 1 minutemin - By Philip Hemme

News and Trends 23 Nov 2015

Making Propane From Gut-Bacteria: A UK-Finland Team Want to Say Ciao to Fracking

Five genes introduced in the bacterial genome of E.coli can modify its metabolism to synthesise propane, which can be then converted to liquified petroleum gas (LPG) as an alternative source of fuel. Escherichia coli is a facultative anaerobe of the genus Escherichia that is commonly found in the lower intestine. An international team of researchers […]

November 23, 2015 - 3 minutesmins - By Joachim Eeckhout

News and Trends 21 Nov 2015

What happened this week? Genfit, History of Biotech, Cellectis

Monday: Interview with the CEO of Genfit – The Billion Euro Liver Biotech on its phase III NASH Drug Tuesday: History of Biotech: How Modern Biotechnology Started-Up 39 Years Ago Wednesday: The UK Catapults Cell Therapy Manufacture into Europe with a €78.5M New Facility Thursday: Why has the Universal CAR-T Treatment For Leukemia Hooked TWO Big Pharmas […]

November 21, 2015 - 1 minutemin - By Philip Hemme

women in biotech movers shakers 2015 biobeats

News and Trends 20 Nov 2015

Get to Know the Top 50 Women in the UK’s Biotech Scene

The Movers & Shakers Report 2015 lists 50 of the Top female Bio-Entrepreneurs… here’s a select few I found particularly impressive in the Biotech Industry! Written by Miranda Weston-Smith, the BioBeat15 report is sponsored by Horton Ruston Poole, Johnson & Johnson Innovation, MedImmune and Pfizer to celebrate what women working in bio-business have brought to […]

November 20, 2015 - 5 minutesmins - By Dani Bancroft

News and Trends 20 Nov 2015

Cinfa Biotech’s Biosimilar is on the Starting Block!

Recently launched Cinfa Biotech just treated the first subjects in a clinical trial with its biosimilar of Neulasta®! Cinfa Biotech just announced that the first subjects have been dosed in a clinical trial of B12019, a biosimilar version of Amgen’s Neulasta® (pegfilgrastim) to treat chemotherapy-induced neutropenia. Though chemotherapy is highly effective against cancer, it is […]

November 20, 2015 - 4 minutesmins - By Joachim Eeckhout

News and Trends 20 Nov 2015

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

This week we say farewell to Austria and head North-West, across the United Kingdom and land in the Emerald Isle, Ireland, where we arrive at our destination, Dublin. The capital city of Ireland is the home of the very famous Irish dry stout, Trinity College (plus its stunning library) and a nearly 900-year-old cathedral. It is […]

November 20, 2015 - 2 minutesmins - By Philip Hemme

Knowledge hub

Categories

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Approaches

Therapeutic areas

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The UK-Israeli €378M Small-Molecule Offensive Against Migraines

Novartis Attacks Amgen. Amgen wants to Ruin Roche – The New Biosimilar War!

Why Biotech Companies Should Care About Native Advertising?

Money Money Money for Immuno-Oncology: BMS Joins up with a Top German VC

2015 Review: What Exciting Developments Have Been Made in Neurodegenerative Disease?

Next Generation Sequencing: the final step to massively adopt Personalized Medicine

Finally, Pfizer acquires Botox-maker Allergan for €150Bn to move to tax-friendly Ireland!

Making Propane From Gut-Bacteria: A UK-Finland Team Want to Say Ciao to Fracking

What happened this week? Genfit, History of Biotech, Cellectis

Get to Know the Top 50 Women in the UK’s Biotech Scene

Cinfa Biotech’s Biosimilar is on the Starting Block!

Biotech of the week: Opsona Therapeutics, The Leading Irish Immuno-Oncology Biotech

Subscribe to our newsletter to get the latest biotech news!

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

The top biotech deals of March 2025

The biggest biotech funding rounds in March 2025

Join the webinar: AI in antibody discovery - from in silico analysis to AI-enabled data management

Beyond amyloid: The search for the next big thing in Alzheimer’s treatment

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!